Li Naomi, Richard Stéphane
Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging, Sir Mortimer B Davis Jewish General Hospital, Lady Davis Institute for Medical Research, Montréal, Québec H3T 1E2, Canada Department of Medicine and Oncology, McGill University, Montréal, Québec H3A 1A1, Canada.
Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging, Sir Mortimer B Davis Jewish General Hospital, Lady Davis Institute for Medical Research, Montréal, Québec H3T 1E2, Canada Department of Medicine and Oncology, McGill University, Montréal, Québec H3A 1A1, Canada
Nucleic Acids Res. 2016 Oct 14;44(18):8726-8741. doi: 10.1093/nar/gkw582. Epub 2016 Jun 30.
Sam68 is a known sequence-specific RNA binding protein that regulates alternative splicing events during the cell cycle and apoptosis. Sam68 has also been shown to influence transcription, but the molecular mechanism remains undefined. Herein we identify Sam68 as a transcriptional coactivator of the p53 tumor suppressor in response to DNA damage. Using CRISPR/Cas9 generated isogenic HCT116 Sam68 cell lines wild type or deficient for p53, we show that Sam68 is required for the efficient transactivation of p53 target genes. Consistently, Sam68 depletion caused defects in DNA damage-induced cell cycle arrest and apoptosis mediated by p53. Mechanistically, we demonstrate that Sam68 physically interacted with p53 in an RNA-dependent manner, and that this interaction was essential for the coactivator function of Sam68. Furthermore, we show that both Sam68 and p53 were recruited to promoters of p53-responsive genes, suggesting interdependence. Finally, Sam68 acted in concert with the p53 long noncoding RNA (lncRNA) target PR-lncRNA-1 for p53 recruitment, implicating a positive-feedback mechanism in which lncRNAs induced by the Sam68/p53 complex can enhance p53 transcriptional activity. These findings define a hitherto novel mechanism of action for Sam68 in governing p53 transcriptional activation, and represent the first report of Sam68 in the regulation of tumor suppressor activities.
Sam68是一种已知的序列特异性RNA结合蛋白,可在细胞周期和细胞凋亡过程中调节可变剪接事件。Sam68也已被证明会影响转录,但其分子机制仍不清楚。在此,我们确定Sam68是p53肿瘤抑制因子在DNA损伤应答中的转录共激活因子。利用CRISPR/Cas9技术构建的野生型或p53缺陷型等基因HCT116 Sam68细胞系,我们发现Sam68是p53靶基因有效反式激活所必需的。一致地,Sam68的缺失导致p53介导的DNA损伤诱导的细胞周期停滞和细胞凋亡出现缺陷。机制上,我们证明Sam68以RNA依赖的方式与p53发生物理相互作用,并且这种相互作用对于Sam68的共激活因子功能至关重要。此外,我们表明Sam68和p53都被招募到p53反应基因的启动子上,表明它们相互依赖。最后,Sam68与p53长链非编码RNA(lncRNA)靶标PR-lncRNA-1协同作用以招募p53,这意味着存在一种正反馈机制,即由Sam68/p53复合物诱导的lncRNAs可增强p53的转录活性。这些发现定义了Sam68在调控p53转录激活方面迄今未知的新作用机制,并代表了Sam68在肿瘤抑制活性调节方面的首次报道。